Back | Next |
home / stock / acad / acad message board
Subject | By | Source | When |
---|---|---|---|
Pretty standard stuff. Most Pharma companies have legal issues | LasNubes | investorshub | 11/23/2022 5:38:39 PM |
OK, that's good but what about this? | gi197845 | investorshub | 11/23/2022 3:15:07 PM |
$ACAD is the plaintiff and filed suit due | LasNubes | investorshub | 11/23/2022 11:58:37 AM |
Wow, yet another lawsuit! | gi197845 | investorshub | 11/23/2022 2:33:53 AM |
Uh oh, Acadia going out of business due | gi197845 | investorshub | 11/22/2022 11:39:39 PM |
Good pop today | harry crumb | investorshub | 11/11/2022 12:27:00 AM |
Things like that happen with bios, its still | harry crumb | investorshub | 08/09/2022 10:23:12 PM |
What about the latest shelf offering and the | gi197845 | investorshub | 08/09/2022 7:40:11 PM |
Ah listen pal, before u make a comment | harry crumb | investorshub | 08/09/2022 1:54:49 AM |
Big mistake listening to Harry Crumb! Keep in | gi197845 | investorshub | 08/05/2022 3:57:27 AM |
Acadia Pharmaceuticals Inc. (Nasdaq: $ACAD) today announced that | gi197845 | investorshub | 08/05/2022 3:21:10 AM |
Smell my shorts, shortie! In your face! | gi197845 | investorshub | 08/03/2022 4:30:22 PM |
State of New Jersey Common Pension Fund D | gi197845 | investorshub | 08/03/2022 2:52:27 PM |
I figured it out. The only reason why | gi197845 | investorshub | 08/02/2022 1:45:50 AM |
Hey foo, I hope your shorting this! | gi197845 | investorshub | 08/02/2022 1:23:49 AM |
I figured it out. The only reason why | gi197845 | investorshub | 08/02/2022 1:05:56 AM |
I agree, Trofinetide is a great, big and | gi197845 | investorshub | 07/21/2022 6:18:49 PM |
with an opened-shirt and flabby belly hanging out | IanFromSI | investorshub | 07/13/2022 5:52:37 PM |
And here's one from only 2 days ago... | IanFromSI | investorshub | 07/13/2022 5:42:00 PM |
- If you really need to go all | IanFromSI | investorshub | 07/13/2022 5:38:45 PM |
News, Short Squeeze, Breakout and More Instantly...
ACADIA Pharmaceuticals Inc. Company Name:
ACAD Stock Symbol:
NASDAQ Market:
ACADIA Pharmaceuticals Inc. Website:
2024-04-30 08:30:07 ET UBS analyst issues BUY recommendation for ACAD on April 30, 2024 06:00AM ET. The previous analyst recommendation was Buy. ACAD was trading at $17.1 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst rec...
-- 10 academic scholarships awarded supporting siblings of Rett syndrome patients Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it has awarded 10 academic scholarships to eligible recipients of the first Rett Sibling Scholarship. The Rett Sibling Scholarship progra...
Company to host conference call and webcast on Wednesday, May 8, 2024, at 4:30 p.m. Eastern Time Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report first quarter financial results on Wednesday, May 8, 2024, after the close of the U.S. financial markets. A...